W. V. Kern Et Al. , "Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV," JOURNAL OF CLINICAL ONCOLOGY , vol.31, no.9, pp.1149-1156, 2013
Kern, W. V. Et Al. 2013. Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV. JOURNAL OF CLINICAL ONCOLOGY , vol.31, no.9 , 1149-1156.
Kern, W. V., Marchetti, O., Drgona, L., AKAN, H., Aoun, M., Akova, M., ... de Bock, R.(2013). Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV. JOURNAL OF CLINICAL ONCOLOGY , vol.31, no.9, 1149-1156.
Kern, Winfried Et Al. "Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV," JOURNAL OF CLINICAL ONCOLOGY , vol.31, no.9, 1149-1156, 2013
Kern, Winfried V. Et Al. "Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV." JOURNAL OF CLINICAL ONCOLOGY , vol.31, no.9, pp.1149-1156, 2013
Kern, W. V. Et Al. (2013) . "Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV." JOURNAL OF CLINICAL ONCOLOGY , vol.31, no.9, pp.1149-1156.
@article{article, author={Winfried V. Kern Et Al. }, title={Oral Antibiotics for Fever in Low-Risk Neutropenic Patients With Cancer: A Double-Blind, Randomized, Multicenter Trial Comparing Single Daily Moxifloxacin With Twice Daily Ciprofloxacin Plus Amoxicillin/Clavulanic Acid Combination Therapy-EORTC Infectious Diseases Group Trial XV}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2013, pages={1149-1156} }